CN114657190A - Msn2p as negative regulatory factor in improving protein expression in host cells - Google Patents

Msn2p as negative regulatory factor in improving protein expression in host cells Download PDF

Info

Publication number
CN114657190A
CN114657190A CN202210356130.3A CN202210356130A CN114657190A CN 114657190 A CN114657190 A CN 114657190A CN 202210356130 A CN202210356130 A CN 202210356130A CN 114657190 A CN114657190 A CN 114657190A
Authority
CN
China
Prior art keywords
expression
gene
host cell
msn2p
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210356130.3A
Other languages
Chinese (zh)
Other versions
CN114657190B (en
Inventor
姚冬生
林香娜
刘大岭
谢春芳
丁伟秋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan University
Original Assignee
Jinan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan University filed Critical Jinan University
Priority to CN202210356130.3A priority Critical patent/CN114657190B/en
Publication of CN114657190A publication Critical patent/CN114657190A/en
Application granted granted Critical
Publication of CN114657190B publication Critical patent/CN114657190B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to application of a transcription regulatory factor for eukaryotic gene expression, in particular to application of a transcription regulatory factor Msn2p of a constitutive promoter Pgap. The invention discloses an application of Msn2p as a negative regulatory factor in improving protein expression in host cells, wherein an amino acid sequence of Msn2p is coded by Msn2 gene with a nucleotide sequence of SEQ ID NO. 1; the application is to increase the expression of a protein in a host cell by knocking out Msn2 gene. The application of the invention can enhance the transcription regulation of a constitutive promoter Pgap in a pichia pastoris expression system by reducing repression, thereby improving the expression efficiency and the yield of target protein.

Description

Msn2p as negative control factor in improving protein expression in host cells
Technical Field
The invention belongs to the field of molecular biology and bioengineering, relates to application of a transcription regulatory factor for eukaryotic gene expression, and particularly relates to application of a transcription regulatory factor Msn2p of a constitutive promoter Pgap.
Background
The promoter is one of the most important elements for regulating gene expression, PAOX1The promoter (inducible) and Pgap promoter (constitutive) are the most representative promoters in the expression of Pichia pastoris foreign proteins.
The expression system of methanol-induced pichia pastoris is a commonly used expression system for expressing most heterologous proteins at present, however, not all the heterologous proteins are suitable for methanol-induced expression, and methanol has great potential safety hazard in large-scale production. Compared with methanol induction, methanol induction is not used when a constitutive pichia pastoris expression system expresses heterologous proteins, but most constitutive promoters are relatively weak in strength, and high protein yield cannot be obtained, so that the application of the constitutive pichia pastoris expression system is limited.
Aiming at the defects of methanol induction, the optimization and modification of a pichia pastoris expression system are a research hotspot in recent years. In the research of promoter modification, new promoter libraries are mainly constructed by various methods at present. Among them, there are many studies to modify PAOX1 by deleting or inserting a cis-acting element in PAOX1, point-mutating the 5' UTR or core promoter region, etc., to result in activation of PAOX1, but these modifications do not appear to be good enough to eliminate inhibition caused by alternative carbon sources such as high levels of glucose and glycerol, and are far from the level of industrial application. For the construction of the Pgap library, the only research is that Qin and the like construct the GAP promoter library by random mutation through error-prone PCR, but the method is random and cannot explain the regulation and control of Pgap. With the application of transcriptome data analysis, the promoter development work is greatly improved. Many reports have been reported on related studies on regulation and improvement of expression intensity of PAOX1, and current studies indicate that methanol can regulate PAOX1 at the transcriptional level by regulating the activity or subcellular localization of multiple trans-acting elements (transcription regulatory factors mainly focused on the PAOX1 promoter or carbon source repression related transcription factors, etc.), thereby affecting the expression of genes related to methanol metabolic pathway. Nevertheless, the mechanisms involved in the regulation of PAOX1 are complex, and the derepression of part of the carbon source does not go beyond the traditional methanol induction in protein expression. At present, the research on promoter regulation is mainly focused on PAOX1, but for the research on exploring Pgap transcription regulation, only Ozge Ata and the like construct a high-expression rhGH strain of a promoter variant by specifically deleting or replicating a Transcription Factor Binding Site (TFBS), and the report of enhancing the yield of a Pgap promoter expression target protein by improving the Pgap promoter transcription regulation in the published literature is almost blank.
According to literature reports, transcription factor Msn2p plays a key role in responding to environmental stress by activating transcription of stress response genes in saccharomyces cerevisiae. Msn2p is assumed to be PAS _ chr2-1_0723 (SEQ ID NO: NC _012964.1) in Pichia pastoris, and the transcriptional regulation of Pgap by the PAS _ chr2-1_0723 has not been reported yet.
Disclosure of Invention
The invention mainly aims to solve the problems and defects of heterologous protein expression in host cells, and provides a transcription factor Msn2p for regulating and controlling the expression of heterologous proteins in host cells, which can enhance the transcription control of a constitutive promoter Pgap in a pichia pastoris expression system by reducing repression, thereby improving the expression efficiency and yield of target proteins.
In the first aspect of the invention, Msn2p is provided as a negative regulatory factor in improving the protein expression in host cells, wherein the amino acid sequence of Msn2p is coded by Msn2 gene with the nucleotide sequence of SEQ ID NO. 1; the application is to increase the expression of a protein in a host cell by knocking out Msn2 gene.
According to the use of the invention, the host cell is selected from: pichia pastoris, Saccharomyces cerevisiae, Candida glycerinogenes.
According to the reports of the prior documents, Pichia pastoris, Saccharomyces cerevisiae, Candida glycerinogenes and the like can all receive yeast expression vectors taking Pgap as a promoter to express heterologous proteins, and therefore, the yeast expression vectors can be used as host cells of the invention.
In a second aspect of the invention, a gene expression cassette for regulating expression of a heterologous protein in a host cell is provided, wherein Pgap is used as a promoter and Msn2 gene is knocked out.
In a third aspect of the invention, a vector is provided, which comprises the gene expression cassette of the invention.
In a fourth aspect of the invention, there is provided a host cell comprising the gene expression cassette of the invention, or comprising the vector of the invention.
In a fifth aspect of the invention, there is provided a method of enhancing protein expression in a host cell, comprising: providing a host cell according to the invention, culturing said host cell under conditions suitable for expression of said heterologous protein, and isolating the expressed protein from the culture medium.
The invention discloses through experiments: msn2 gene is knocked out in a heterologous protein synthesis path with Pgap as a promoter, a transcription factor Msn2p is formed after the sequence is translated and participates in the reverse regulation of the Pgap promoter, and the repression expression of a subsequent exogenous gene with the Pgap as the promoter is removed, so that the non-induced mass accumulation of the target protein is realized.
The gene expression cassette which takes Pgap as a promoter and knocks out Msn2 gene can be constructed, and the knockout of Msn2p transcription inhibiting factors can enhance the transcription of a constitutive promoter Pgap promoter of pichia pastoris, so that exogenous genes in the gene expression cassette are efficiently expressed in the pichia pastoris (or other yeasts which can accept Pgap as a promoter), and the expression strength of the exogenous genes can be obviously improved.
Drawings
FIG. 1 is a map of an Msn2 gene knockout expression cassette; a picture shows a kan gene substitution knockout expression cassette; panel b is a full knockout expression cassette.
FIG. 2 shows the growth rate of xylanase xynB expressed by the strain of the invention (Pichia pastoris), wherein the control group is an un-knocked-out strain; clone 1 and clone 2 were Msn2 knock-out strains.
Detailed Description
The technical solution of the present invention will be further described in detail with reference to the following embodiments. It is to be understood that the following examples are only illustrative and explanatory of the present invention and should not be construed as limiting the scope of the present invention. All the technologies realized based on the above-mentioned contents of the present invention are covered in the protection scope of the present invention.
Unless otherwise indicated, the raw materials and reagents used in the following examples are all commercially available products or can be prepared by known methods. The molecular cloning techniques employed in the following examples are described in the molecular cloning guidelines, compiled by J.Sammlung et al, or as recommended by the manufacturer.
Herein, Msn2p denotes a protein expressed by Msn2 gene.
Example 1: construction of Kan gene replacement transcription inhibitor Msn2 gene knockout expression cassette
1. Amplification of upstream homology arms
The invention takes the genome sequence of pichia pastoris as reference, adopts software DNAMAN 8 to design and synthesize two oligonucleotide primers, and amplifies the upstream homology arm sequence of Msn2 gene (the sequence is SEQ ID NO:1) by a PCR method.
The two PCR primers were as follows:
1-F:ACTTACGAGCTCGGCTCAGTGGCTTTCCATCTGTT(SEQ ID NO:4)
1-R:CTTACGCGGATCCGCGTCTAGTTAATCGCAAAC(SEQ ID NO:5)
underlined bases are the SacI and BamHI restriction enzyme sites, respectively.
The PCR reaction system is shown in Table 1 below.
Table 1:
components Volume (μ L)
2×Q5 Master Mix 12.5
Primer F(10μM) 1.25
Primer R(10μM) 1.25
Template DNA 1(100ng)
ddH2O 9ul
Total volume 25ul
The PCR program was set up as in Table 2 below.
Table 2:
Figure BDA0003582991800000041
the PCR amplification product was subjected to 1% agarose gel electrophoresis, and gel recovery was carried out using a DNA recovery kit to obtain a fragment of about 1000 bp.
2. Amplification of downstream homology arms
The invention takes the genome sequence of pichia pastoris as reference, adopts software DNAMAN 8 to design and synthesize two oligonucleotide primers, and amplifies the downstream homology arm sequence of Msn2 gene by PCR method.
The two PCR primers were as follows:
2-F:ACTTATTTGCGGCCGCTTTAAGGAATTGGGAAGGTTTTATATT(SEQ ID NO:6)
2-R:ACTTAGTTTCTTCGTCGACTCTTTTATTGAGCCTGTGTC(SEQ ID NO:7)
underlined bases are SalI and NotI restriction enzyme cutting sites respectively.
The PCR reaction system and PCR program set up the amplification method of the upstream homology arm as described above.
The PCR amplification product was subjected to 1% agarose gel electrophoresis, and gel recovery was carried out using a DNA recovery kit to obtain a fragment of about 1000 bp.
3. Amplification of Kan Gene
In the invention, the Kan gene (kanamycin resistance gene which can express G418 resistance in a cell) of a ppic3.5k plasmid (from Invitrogen company) is used as a reference, two oligonucleotide primers are designed and synthesized by adopting software DNAMAN 8, and the Kan gene is amplified by a PCR method.
The two PCR primers were as follows:
3-F:ACTTACGCGGATCCGCGATGAGCCATATTCAAC(SEQ ID NO:8)
3-R:ACTTACCGGAATTCCGGTTAGAAAAACTCATCGAG(SEQ ID NO:9)
underlined bases are the restriction sites for BamHI and EcoRI respectively.
The PCR reaction and PCR program were set as described above.
After the PCR amplification product was subjected to 1% agarose gel electrophoresis, gel recovery was carried out using a DNA recovery kit to obtain a fragment of about 816 bp.
4. Ligation of the ppic3.5k vector to the Kan fragment
The ppic3.5K plasmid and the Kan gene PCR product were digested with restriction enzymes EcoRI and BamHI, respectively, at 37 ℃ for 20min under the conditions shown in Table 3 below.
Table 3:
components Volume (μ L)
10 XCutsmart buffer 1
Plasmid 1 (about 200ng)
EcoRI、BamHI 0.2
ddH2O 7.6
Total volume 10
After electrophoresis of the enzyme digestion product on 1% agarose gel, two target fragments were recovered respectively and ligated with T4DNA ligase, the ligation system is shown in Table 4 below.
Table 4:
Figure BDA0003582991800000051
Figure BDA0003582991800000061
and (2) connecting for 12h by using ligase at 16 ℃, transforming DH5a competent cells by using a connection product, amplifying, extracting plasmids by using a plasmid extraction kit, carrying out double enzyme digestion by using EcoRI and BamHI, carrying out electrophoresis, and indicating that two bands of 9kb and 816bp exist, wherein the successful connection is indicated, and the DNA sequencing is carried out to determine the gene as Kan.
5. The upstream homology arm fragment is connected with a ppi3.5k-Kan carrier
The upstream homologous arm fragment and the ppi3.5k-Kan vector are obtained by double digestion with restriction enzymes SacI and BamHI respectively and purification and recovery.
The method for connecting the upstream homology arm fragment and the ppi3.5k-Kan vector is the same as the step 4, the electrophoresis result after the double digestion by SacI and BamHI shows that two bands of 9kb and 1kb are provided, the connection is successful, and the upstream homology arm fragment is determined by DNA sequencing (the sequence is SEQ ID NO: 2).
6. The downstream homology arm fragment is connected with a ppic3.5k- (upstream homology arm) -Kan carrier
The downstream homology arm fragment and the ppic3.5k- (upstream homology arm) -Kan vector are obtained by double digestion, purification and recovery of restriction enzymes EcoRI and NotI respectively.
The method for connecting the downstream homology arm fragment and the ppic3.5k- (upstream homology arm) -Kan vector is the same as that in step 4, the electrophoresis result after double digestion by SalI and NotI shows that two bands of 8kb and 1kb are displayed, the connection is successful, and the downstream homology arm fragment is determined by DNA sequencing (the sequence is SEQ ID NO: 3).
Thus, the Kan gene replacement transcription repressing factor Msn2 gene knockout expression cassette is successfully constructed (as shown in a picture of figure 1).
Example 2: construction of complete knockout expression cassette of transcription repressing factor Msn2 gene
The homology arms above and below the Msn2 gene were amplified using primers 1-F, 1-R, and 2-F, 2-R as in example 1, and the upstream and downstream homology arm fragments were ligated to the ppic3.5k vector by the above-described enzymatic ligation to construct a ppic3.5k- (upstream homology arm) - (downstream homology arm) knockout expression cassette.
Example 3: pichia pastoris genome Msn2 knock-out
In order to improve the integration efficiency of the single copy expression cassette on the chromosome of pichia pastoris, the knockout expression cassette is linearized by restriction enzymes SacI and NotI and purified and recovered by a kit. The recipient bacterium of the experiment is pichia pastoris SMD1168 (recombinant bacterium containing xylanase xynB gene inserted after Pgap, EX6), the knockout expression cassette of example 1 is electrically transformed, and then screened by using a G418 plate containing 0.3mg/mL, and genome PCR identification is carried out. Example 2 knock-out expression cassettes were electrotransformed and screened using YPG plates and genomic PCR identification was provided.
The PCR product sequencing result shows that the screened strain is a positive clone which successfully knocks out Msn 2.
Example 4: msn2 knock-out strain constitutive promoter Pgap driven heterologous protein expression assay
The positive clone 1 selected in example 1 and the positive clone 2 selected in example 2 were fermented at 28 ℃ and 200rpm for 72 hours. Meanwhile, pichia pastoris (EX6) containing xynB genes is used as a control, after culture for 72h, supernatant is taken to carry out SDS-PAGE electrophoresis detection, and the expression level of xylanase xynB is analyzed.
The results are shown in fig. 2, the expression level of the positive clone 1 picked after knocking out Msn2p transcription factor is increased by 118% compared with the control group, and the expression level of the positive clone 2 is increased by 50% compared with the control group.
SEQUENCE LISTING
<110> river-south university
Application of <120> Msn2p as negative regulatory factor in improving protein expression in host cells
<130>
<160> 9
<170> PatentIn version 3.5
<210> 1
<211> 1071
<212> DNA
<213> Pichia pastoris
<400> 1
atgtctacaa caaaaccaat gcaggtgtta gccccggacc ttactgagac accaaagaca 60
tattcgttag gtgtccattt ggggaaaggc aaggacaaac tccaggatcc gacagaactc 120
tactcgatga tcctagatgg aatggatcac tcacagctca attcttttat taacgatcag 180
ttgaacttgg gatcattgcg cttgccggcg aatcctcctg ctgcaagtgg tgctaaacgg 240
ggtgcaaatg tcagttctat caacatggat gatttacaaa cgtttgattt caactttgat 300
tacgaacggg attcatcgcc gctagaattg aacatggatt ctcaatcttt gatgttttcc 360
tctccagaga aagctccctg tggctccttg ccgtctcagc atcagcctca ctctcaggtc 420
gcagccgcac agggaactac catcaatcca aggcagttat ccacatcttc tgccagtagc 480
tttgtatctt cggattttga tgttgattca ctcctggcag acgagtacgc tgagaaacta 540
gaatatggag ccatatcatc tgcctcatct tccatctgtt cgaattctgt tcttcctagc 600
cagggcgtaa cttcgcaaca tagctctcct atagaacaga gacctcgtgt gggaaattcc 660
aaacgcttga gtgatttttg gatgcaggac gaagctgtca ctgccatttc cacctggctc 720
aaagctgaaa taccttcctc cttggctacg ccggctccta cagtcacaca aataagtagt 780
cccagcctta gcaccccaga gccaaggaag aaagaaacaa aacaaagaaa gagggcaaag 840
tccatagaca cgaatgagcg atctgaacaa gtagcagctt ctaattcaga tgatgaaaag 900
caattccgct gcacggattg cagtagacgc ttccgcagat cagaacacct gaaacgacat 960
cataggtctg ttcattctaa cgaaaggccg ttccattgtg ctcactgtga taaacggttc 1020
tcaagaagcg acaacttgtc gcagcatcta cgtactcacc gtaagcagtg a 1071
<210> 2
<211> 1001
<212> DNA
<213> Artificial Synthesis
<400> 2
gctcagtggc tttccatctg tttgatagac agaagatctc gaggtattga ttgaagccat 60
tgcgatgatt tggtcaatca aacactataa agcaaaggat agataaaaga gaaccaagaa 120
aatatagaat tagacaggtc atcagaataa tcactgcacc accacaacag taggggcagc 180
aactatgaga tgttgcctaa tcaggccata gtgtaaagaa actcctaatt aggaaagaac 240
ctcatccata cttttgaaac tttgaaagct tcaagtcacg tgctacccag aatccaacat 300
caagcattct tttggtcctg cggctcgtga gtccaacaaa gaaatgtgct atgttgagcg 360
tcgcgcatat ctattcatga ctcagtcagg ctggagggtg atgcaattgc gacttcggaa 420
gtaaaacgtc attattgttg tgtcgtacac acagactatt caaattccga aaagattatt 480
gaaaaatatc acgtgaatac cccagttgtg taaaagcggt agtatctact acctcttcac 540
gtgacttaat tgcttcttga atcaacataa cggctgtaaa tgtgatcatc aggaatgaaa 600
atagaaaaaa aaaattctga cactaaacgg aaggacgcgg gaggcactaa actgaatcta 660
acaagactac gaatagagct atttcaaaca tgaaaaaaga ctgaatggcc ctataattcg 720
cctgtatatg taggtctctc ctccaccttt cagcagatca aaaagataaa ccataaacgg 780
ccaaaatgtg cgcgagagaa caataggaat cgtacacaac taaattgagt aaatgtgggc 840
ctgggcttat ttttcctcgc aatacatata tatatacact actttatatt acctcatata 900
taagaattcc cccggtagcc tgttccagca gtttgaatta atttcgattg tcaattggtt 960
gaatcagttt gattatttgg gtttgtttgc gattaactag a 1001
<210> 3
<211> 1001
<212> DNA
<213> Artificial Synthesis
<400> 3
aggaattggg aaggttttat attgggtttt tgttacatag ttttgggttg gttttattac 60
atttctttta cgttacactg tggtggtttg ttggctgtat caaacggaga cttctccatg 120
atctctgttc tgtagtatct tgctcatttt ttctctctta atactgcttg ttggaagtcg 180
tacattatat cgtaccgtct accagtttgc ccagtcgctc tctcaatgga ggttgtgatt 240
cgctctccat caatgatagt agcgtattca gatgtgccag tttcgcatct atggagttta 300
ttgtttcact ggagttttga gcttcttctt cgaaatcccc taaaagttgt tgcgtctgcg 360
tttccaacaa gttgacctgc gaccgcaagt tatctctcaa ttctctccgc tcttgtatag 420
tttgactttg aataagtttc tcgggtgtta agtcctctag atttagagat tcctctacag 480
caccagtatt ctttctcttt tgcgcttgcc atattaactt atctagttca tccaatttac 540
tctcaacatt tctttctttg aatatcttat caaactcagt cactgcgctg gtctcccaga 600
atgttatcat ttgctccctg gctacttgaa ggtgccgttt acctacatcg tttgcgctta 660
tctgaggata gcacatgtca aatttcgtag agttcaattc ttgagttgtg ttagctagtg 720
ccttgtgaag aaccctctcc aagattttgc ttcggaactt gggaggattt tggtcatcct 780
ctgtagtatt cacttcccta gggctcattt aatatcaaca aaattgtaat gtttatgtaa 840
tgcaacgtta tgtaaatagt ctccaccgcc ccaatatacc tcttagggct tagtattttc 900
attaattttt tttttcttac taagaattat tgaaccccat cacatctgtt attcactatg 960
aaattgttgg ttgccttaga ggacacaggc tcaataaaag a 1001
<210> 4
<211> 35
<212> DNA
<213> Artificial Synthesis
<400> 4
acttacgagc tcggctcagt ggctttccat ctgtt 35
<210> 5
<211> 33
<212> DNA
<213> Artificial Synthesis
<400> 5
cttacgcgga tccgcgtcta gttaatcgca aac 33
<210> 6
<211> 43
<212> DNA
<213> Artificial Synthesis
<400> 6
acttatttgc ggccgcttta aggaattggg aaggttttat att 43
<210> 7
<211> 39
<212> DNA
<213> Artificial Synthesis
<400> 7
acttagtttc ttcgtcgact cttttattga gcctgtgtc 39
<210> 8
<211> 33
<212> DNA
<213> Artificial Synthesis
<400> 8
acttacgcgg atccgcgatg agccatattc aac 33
<210> 9
<211> 35
<212> DNA
<213> Artificial Synthesis
<400> 9
acttaccgga attccggtta gaaaaactca tcgag 35

Claims (6)

1, Msn2p as negative regulation factor in improving the host cell protein expression application, characterized by, the amino acid sequence of Msn2p is encoded by Msn2 gene whose nucleotide sequence is SEQ ID NO. 1; the application is to increase the expression of a protein in a host cell by knocking out Msn2 gene.
2. The use according to claim 1, wherein said host cell is selected from the group consisting of: pichia pastoris, Saccharomyces cerevisiae, Candida glycerinogenes.
3. A gene expression cassette for regulating expression of a heterologous protein in a host cell, wherein the Msn2 gene is knocked out using Pgap as a promoter.
4. A vector, characterized by: which contains the gene expression cassette of claim 2.
5. A host cell, characterized in that: comprising the gene expression cassette of claim 2 or comprising the vector of claim 3.
6. A method of enhancing protein expression in a host cell, comprising: providing a host cell according to claim 4, culturing said host cell under conditions suitable for expression of said heterologous protein, and isolating the expressed protein from the culture medium.
CN202210356130.3A 2022-04-06 2022-04-06 Application of Msn p as negative regulatory factor in improving protein expression in host cells Active CN114657190B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210356130.3A CN114657190B (en) 2022-04-06 2022-04-06 Application of Msn p as negative regulatory factor in improving protein expression in host cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210356130.3A CN114657190B (en) 2022-04-06 2022-04-06 Application of Msn p as negative regulatory factor in improving protein expression in host cells

Publications (2)

Publication Number Publication Date
CN114657190A true CN114657190A (en) 2022-06-24
CN114657190B CN114657190B (en) 2023-08-29

Family

ID=82035498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210356130.3A Active CN114657190B (en) 2022-04-06 2022-04-06 Application of Msn p as negative regulatory factor in improving protein expression in host cells

Country Status (1)

Country Link
CN (1) CN114657190B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101679992A (en) * 2007-04-20 2010-03-24 波利门科学生物免疫研究有限公司 Expression system
CN106701787A (en) * 2016-07-29 2017-05-24 江南大学 Pichia pastoris for expressing foreign proteins, construction method of pichia pastoris and induced expression method of pichia pastoris
US20180223293A1 (en) * 2015-08-05 2018-08-09 Lonza Ltd Promoter Variants
CA3125217A1 (en) * 2019-01-11 2020-07-16 Lonza Ltd Carbon-source regulated protein production in a recombinant host cell
CN112955547A (en) * 2018-06-27 2021-06-11 贝林格尔·英格海姆Rcv两合公司 Means and methods for increasing protein expression by use of transcription factors
CN113528527A (en) * 2021-07-29 2021-10-22 华东理工大学 Promoter for recombinant protein expression and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101679992A (en) * 2007-04-20 2010-03-24 波利门科学生物免疫研究有限公司 Expression system
US20180223293A1 (en) * 2015-08-05 2018-08-09 Lonza Ltd Promoter Variants
CN106701787A (en) * 2016-07-29 2017-05-24 江南大学 Pichia pastoris for expressing foreign proteins, construction method of pichia pastoris and induced expression method of pichia pastoris
CN112955547A (en) * 2018-06-27 2021-06-11 贝林格尔·英格海姆Rcv两合公司 Means and methods for increasing protein expression by use of transcription factors
CA3125217A1 (en) * 2019-01-11 2020-07-16 Lonza Ltd Carbon-source regulated protein production in a recombinant host cell
WO2020144313A1 (en) * 2019-01-11 2020-07-16 Lonza Ltd Carbon-source regulated protein production in a recombinant host cell
CN113528527A (en) * 2021-07-29 2021-10-22 华东理工大学 Promoter for recombinant protein expression and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DE SCHUTTER,K. ET AL: "ACCESSION NO.XM_002491607,Komagataella phaffii GS115 uncharacterized protein (PAS_chr2-1_0723), partial mRNA", 《GENBANK》 *
皇甫洁: "基于模拟微重力响应下毕赤酵母外源蛋白质高效表达***的调控", 《中国博士学位论文全文数据库 基础科学辑》, no. 5, pages 4 *

Also Published As

Publication number Publication date
CN114657190B (en) 2023-08-29

Similar Documents

Publication Publication Date Title
EP0292609B1 (en) Process and signal sequence for the extracellular production of proteinaceous material
US20170088845A1 (en) Vectors and methods for fungal genome engineering by crispr-cas9
CN110331158B (en) Simultaneous editing method of polygene loci based on zymomonas mobilis endogenous CRISPR-Cas system and application thereof
AU2017224865A1 (en) Expression system for eukaryotic organisms
CN109762819B (en) Constitutive promoter of pleurotus eryngii and application thereof
CN111763678B (en) Promoter for improving activity of heterologous expression enzyme of keratinase
CN114657190B (en) Application of Msn p as negative regulatory factor in improving protein expression in host cells
CN114774461B (en) Application of Ash1p as negative regulatory factor in improving protein expression in host cell
JPS6394969A (en) Yeast strain improved for development of exotic gene
CN113056554A (en) Recombinant yeast cells
JP4413557B2 (en) Efficient production of proteins using filamentous fungi
CN116555269B (en) Bumblebee candida utilis inducible promoter and application thereof
CN115948427B (en) Coroxepin FHb, recombinant bacterium X33-pPICZ alpha A-102C300C-FHb1 and application thereof
EP3802820B1 (en) Methods for identifying promoters for protein production in yeast
CN115058443B (en) Transcription inhibition plasmid pCRISPR-nadG and application thereof in improving intracellular reducing power of solvolytic clostridium
JP3290108B2 (en) DNA sequence that increases promoter activity
KR101392968B1 (en) Novel autonomously replicating sequence and uses thereof
CN117305137A (en) Homologous over-expression engineering bacterium of laccase gene MvLac5 and application thereof
CN116837006A (en) Ganoderma lucidum peroxidase GlyP gene and encoding protein and application thereof
JP5686974B2 (en) New terminators and their use
CN115960802A (en) Engineering bacterium of vibrio natriegens for high yield recombination protein and its application
JP2018078883A (en) Novel high temperature resistance imparting gene and method of using same
CN117247924A (en) Ame1-FgTad2-FgTad3 editing enzyme system, editing tool and editing method
CN116837012A (en) Method for improving feruloyl esterase expression secretion amount
CN116769616A (en) Mutant library, method for screening high-expression or low-expression sites in aspergillus niger by using mutant library and application of mutant library

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant